Literature DB >> 16733352

Relationship between aortic valve sclerosis and the extent of coronary artery disease in patients undergoing diagnostic coronary angiography.

Serdar Soydinc1, Vedat Davutoglu, Ayhan Dundar, Mehmet Aksoy.   

Abstract

BACKGROUND: Aortic valve sclerosis (AVS) is considered to be a manifestation of coronary atherosclerosis. Recent studies demonstrated an association between AVS and significant coronary artery disease (CAD). AIM: We sought to determine the association between AVS and the extent of coronary atherosclerosis by means of the Gensini score system, which was calculated to yield a measure of the extent and severity of coronary atherosclerosis in patients referred for coronary angiography.
METHODS: A total of 160 consecutive patients referred for coronary angiography were subjected to echocardiography for screening of AVS and coronary risk assessment. Absence (group 1, n = 110) and presence of AVS (Group 2, n = 50) was established. The cardiac risk factors considered in this study were age, gender, family history of CAD, diabetes mellitus, hypertension, hypercholesterolemia and history of smoking. The body mass index was also measured. Atherosclerotic plaque burden was determined using the Gensini score. Significant CAD was defined as >50% reduction in the internal diameter of at least one coronary artery. Multivessel coronary disease was based on the presence of 2- or 3-vessel disease.
RESULTS: The AVS patients had a higher rate of 3-vessel disease (AVS group vs. non AVS: 40 vs. 13.6%; p < 0.001). No significant correlations were found between AVS and 1- and 2-vessel disease. Individuals with AVS were found to have a higher Gensini score (40.7 +/- 38.05 vs. 18 +/- 16.4; p < 0.001). Multivariate analysis identified age (p < 0.001), male sex (p = 0.01), triglycerides (p = 0.02), LDL cholesterol (p = 0.001) and Gensini score (p = 0.003) as independent predictors of AVS.
CONCLUSION: AVS is strongly interrelated with the coronary angiographic Gensini score. Echocardiographic detection of AVS in patients undergoing coronary angiography can provide a new surrogate marker of the extent of coronary atherosclerosis. 2006 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2006        PMID: 16733352     DOI: 10.1159/000093491

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  7 in total

1.  Olfactory ensheathing cells promote neurite sprouting of injured axons in vitro by direct cellular contact and secretion of soluble factors.

Authors:  R S Chung; A Woodhouse; S Fung; T C Dickson; A K West; J C Vickers; M I Chuah
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

2.  Does aortic valve sclerosis predicts the severity and complexity of coronary artery disease?

Authors:  Hemal Bhatt; Dharmesh Sanghani; Kell Julliard; George Fernaine
Journal:  Indian Heart J       Date:  2015-04-27

3.  Link between aortic valve sclerosis and myocardial no-reflow in ST-segment elevation myocardial infarction.

Authors:  L Korkmaz; H Erkan; M T Ağaç; E Pelit; H Bektas; Z Acar; I Gurbak; F Kara; Ş Çelik
Journal:  Herz       Date:  2014-01-19       Impact factor: 1.443

4.  Aortic valve sclerosis in acute coronary syndrome patients : potential value in predicting coronary artery lesion complexity.

Authors:  L Korkmaz; E Pelit; H Bektas; M T Ağaç; H Erkan; I Gurbak; Ş Çelik
Journal:  Herz       Date:  2013-09-27       Impact factor: 1.443

Review 5.  Valve Calcification in Aortic Stenosis: Etiology and Diagnostic Imaging Techniques.

Authors:  María Manuela Izquierdo-Gómez; Iván Hernández-Betancor; Javier García-Niebla; Belén Marí-López; Ignacio Laynez-Cerdeña; Juan Lacalzada-Almeida
Journal:  Biomed Res Int       Date:  2017-07-24       Impact factor: 3.411

6.  Calcific aortic valve damage as a risk factor for cardiovascular events.

Authors:  Jarosław Wasilewski; Kryspin Mirota; Krzysztof Wilczek; Jan Głowacki; Lech Poloński
Journal:  Pol J Radiol       Date:  2012-10

Review 7.  Insights into aortic sclerosis and its relationship with coronary artery disease.

Authors:  Alexandra C Milin; Gabriel Vorobiof; Olcay Aksoy; Reza Ardehali
Journal:  J Am Heart Assoc       Date:  2014-09-05       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.